Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
13 Fevereiro 2025 - 4:08PM
UK Regulatory
Press Release: Filing of the 2024 U.S. Form 20-F and French
“Document d’Enregistrement Universel” containing the Annual
Financial Report
Filing of the 2024 U.S. Form 20-F and French
“Document d’Enregistrement Universel” containing the Annual
Financial Report
Paris, February 13, 2025.
Sanofi announces today the filing of its Form 20-F with the U.S.
Securities and Exchange Commission (SEC) and its “Document
d’Enregistrement Universel” containing its Annual Financial Report
with the French market regulator Autorité des marchés financiers
(AMF).
These documents are available on the company’s
website:
https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information
In addition, the Form 20-F is available on the
website of the SEC (www.sec.gov) and the “Document d’Enregistrement
Universel” is available on the website of the AMF
(www.amf-france.org). A hard copy of these documents, each of which
contains our complete audited financial statements, may be received
free of charge, upon request.
About Sanofi
We are an innovative global healthcare company, driven by one
purpose: we chase the miracles of science to improve people’s
lives. Our team, across some 100 countries, is dedicated to
transforming the practice of medicine by working to turn the
impossible into the possible. We provide potentially life-changing
treatment options and life-saving vaccine protection to millions of
people globally, while putting sustainability and social
responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Media Relations
Sandrine Guendoul | + 33 6 25 09 14 25
| sandrine.guendoul@sanofi.com
Victor Rouault | + 33 6 70 93 71 40
| victor.rouault@sanofi.com
Investor Relations
Thomas Kudsk Larsen |+ 44 7545 513 693 |
thomas.larsen@sanofi.com
Alizé Kaisserian | + 33 6 47 04 12 11 |
alize.kaisserian@sanofi.com
Felix Lauscher | + 1 908 612 7239 |
felix.lauscher@sanofi.com
Keita Browne | + 1 781 249 1766 |
keita.browne@sanofi.com
Nathalie Pham | + 33 7 85 93 30 17 |
nathalie.pham@sanofi.com
Tarik Elgoutni | + 1 617 710 3587 |
tarik.elgoutni@sanofi.com
Thibaud Châtelet | + 33 6 80 80 89 90 |
thibaud.chatelet@sanofi.com
Sanofi (EU:SAN)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Sanofi (EU:SAN)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025